Evidence map›Paper›PMID 36680257›Full record

ArticleViruses2023

Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity.

Federica Bichicchi, Niccolò Guglietta, Arthur Daniel Rocha Alves, Erika Fasano, Elisabetta Manaresi, Gloria Bua, Giorgio Gallinella

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Federica BichicchiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-2004-2841
Niccolò GugliettaDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Arthur Daniel Rocha AlvesLaboratory of Technological Development in Virology, Oswaldo Cruz Foundation/FIOCRUZ, Brasil Avenue 4365, Manguinhos, Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-6371-6482
Erika FasanoDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Elisabetta ManaresiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Gloria BuaDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Giorgio GallinellaDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-1118-6341
University of Bologna · ITFundação Oswaldo Cruz · BRIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parvovirus B19 (B19V) is a ssDNA human virus, responsible for an ample range of clinical manifestations. Sequencing of B19V DNA from clinical samples is frequently reported in the literature to assign genotype (genotypes 1-3) and for finer molecular epidemiological tracing. The increasing availability of Next Generation Sequencing (NGS) with its depth of coverage potentially yields information on intrinsic sequence heterogeneity; however, integration of this information in analysis of sequence variation is not routinely obtained. The present work investigated genomic sequence heterogeneity within and between B19V isolates by application of NGS techniques, and by the development of a novel dedicated bioinformatic tool and analysis pipeline, yielding information on two newly defined parameters. The first, α-diversity, is a measure of the amount and distribution of position-specific, normalised Shannon Entropy, as a measure of intra-sample sequence heterogeneity. The second, σ-diversity, is a measure of the amount of inter-sample sequence heterogeneity, also incorporating information on α-diversity. Based on these indexes, further cluster analysis can be performed. A set of 24 high-titre viraemic samples was investigated. Of these, 23 samples were genotype 1 and one sample was genotype 2. Genotype 1 isolates showed low α-diversity values, with only a few samples showing distinct position-specific polymorphisms; a few genetically related clusters emerged when analysing inter-sample distances, correlated to the year of isolation; the single genotype 2 isolate showed the highest α-diversity, even if not presenting polymorphisms, and was an evident outlier when analysing inter-sample distance. In conclusion, NGS analysis and the bioinformatic tool and pipeline developed and used in the present work can be considered effective tools for investigating sequence diversity, an observable parameter that can be incorporated into the quasispecies theory framework to yield a better insight into viral evolution dynamics.

Indexed as

Parvovirus B19, HumanDNA, ViralGenomicsGenotypeHigh-Throughput Nucleotide SequencingDNA, Viralcluster analysisgenetic diversityNext Generation SequencingParvovirus B19Shannon Entropyviral quasispecies

Identifiers

PMID36680257
PMCPMC9863757
OpenAlexW4315797856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.